White matter recovery

White matter recovery is a complex biological process aimed at restoring the structural and functional integrity of myelinated axons in the central nervous system (CNS) following damage (Source: Nature Reviews Neuroscience, 2008). It primarily involves remyelination, where new myelin sheaths are generated around denuded axons by mature oligodendrocytes derived from recruited oligodendrocyte precursor cells (OPCs). This process is essential for restoring saltatory conduction and providing metabolic support to axons, thereby preventing permanent axonal degeneration in diseases like multiple sclerosis (MS), stroke, and traumatic brain injury (Source: The Lancet Neurology, 2019). While white matter recovery occurs naturally, it is often incomplete or fails in chronic disease states due to inhibitory factors in the lesion environment or the failure of OPCs to differentiate. Therapeutic strategies targeting white matter recovery include the use of small molecules like clemastine to promote OPC maturation or monoclonal antibodies like opicinumab to block inhibitory signaling pathways such as LINGO-1 (Source: The Lancet, 2017). Monitoring this process in clinical trials relies heavily on advanced neuroimaging techniques like Magnetization Transfer Ratio (MTR) and Diffusion Tensor Imaging (DTI) to quantify myelin density and structural connectivity.

Other names

RemyelinationWhite matter repairAxonal regenerationMyelin repair

Promotion of oligodendrocyte precursor cell (OPC) differentiation and maturation, inhibition of myelination-inhibitory proteins (e.g., LINGO-1, RGMa), and activation of nuclear receptors (e.g., RXR-gamma) to stimulate myelin gene expression.